Genzyme Corporation is pursuing lawsuits against Lupin Ltd. and Lupin Pharmaceuticals and Impax Laboratories, Inc., alleging infringement of Renagel and Renvela patents.
Beginning in January 2009, the company received notices from…
Genzyme Corporation is pursuing an amended patent infringement complaint against Pentech Pharmaceuticals, Inc.
In January 2008, the company received notice that Pentech had submitted to the U.S. Food and Drug Administration…
No trial date has been set for the litigation between Shire Ltd. and Apotex Inc., Apotex Corp. and Apotex Pharmaceutical Holdings Inc. for the alleged infringement of U.S. Patent Nos.…
Actavis Elizabeth LLC’s suit against the U.S. Food and Drug Administration remains stayed, according to Shire Ltd.’s latest Quarterly Report filed with the U.S. Securities and Exchange Commission.
On Feb. 24,…
The settlement of the patent infringement suit captioned “Forest Laboratories, Inc. et al. v. Caraco Pharmaceutical Laboratories, Ltd. et al.,” remains subject to review by the U.S. Federal Trade Commission.
In…
Pfizer Inc. said it will file an action in the Canadian Federal Court in Toronto to prevent approval of Genpharm Inc.’s proposed generic product.
In July 2009, Genpharm Inc. served notice…
Allergan Inc., Endo Pharmaceuticals Solutions, Inc., and Supernus Pharmaceuticals, Inc. pursue a patent infringement complaint against Watson, Watson Laboratories, Inc. — Florida, and Watson Pharma, Inc.
In June 2009, the Company…
A trial date has been set for April 5, 2010, on Forest Laboratories Inc.’s patent infringement complaint against generic manufacturers of Namenda, the Company’s N-methyl-D-aspartate.
During the third quarter of fiscal…
Allergan Inc.’s patent infringement complaint against Hi-Tech Pharmacal Co., is pending in the U.S. District Court for the Eastern District of Texas.
In April 2009, the Company received paragraph 4 invalidity…
Metabolite Laboratories Inc.’s appeal from the U.S. District Court for the District of Colorado’s judgment in the patent suit filed by Competitive Technologies Inc. and Metabolite against Laboratory Corp. of…